Hospital for Special Surgery - Archive (Clinical Trials)

2019
September
24,
2019
| 05:07 PM America/New_York
An international, multicenter phase II clinical trial is evaluating the efficacy and safety of mavrilimumab co-administered with a 26-week corticosteroid taper in patients with giant cell arteritis (GCA). The study is sponsored by Kiniksa Pharmaceuti...
Read more
September
19,
2019
| 08:05 PM America/New_York
Insulin-like growth factor 1 (IGF1) is essential for allowing tendons to adapt to physical activity and grow properly, according to basic science research by investigators at Hospital for Special Surgery (HSS). The findings provide a strong rationale...
Read more
September
10,
2019
| 03:10 PM America/New_York
Scott A. Rodeo, MD, a sports medicine surgeon and clinician-scientist at Hospital for Special Surgery (HSS) has launched a clinical trial of an experimental engineered cell therapy that aims to promote better healing of rotator cuff tears after surge...
Read more
July
08,
2019
| 11:09 PM America/New_York
Healio Primary Care featuring Bella Mehta, MBBS, MD, MS ...
Read more
January
09,
2019
| 01:00 PM America/New_York
Researchers at Hospital for Special Surgery in New York City are leading a pivotal clinical trial on a new investigational surgical treatment for osteoarthritis (OA) of the knee that is designed to offer improved mobility and reduced pain without the...
Read more